ArticleFrontiers in oncology2026

Case report: complete pathologic response to neoadjuvant ensartinib in locally advanced, ALK-positive lung squamous cell carcinoma.

Yingyu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.